generated: '2026-08-21'
method: searched
source: https://genomind.com/cost-and-coverage/
note: >-
  Genomind sells a laboratory test, not an API product, so there are no API plans, quotas or
  overages to record. The only published price is the consumer self-pay price for the At-Home PGx
  test. Provider/health-system pricing and the EMR interface are quoted through sales and are not
  published. plan_count counts the one published, priced offering.
plan_count: 1
currency: USD
plans:
- name: Genomind At-Home PGx Test (self-pay)
  price: 599
  currency: USD
  billing_period: one-time
  audience: US residents (direct-to-consumer)
  included: >-
    One 26-gene pharmacogenetic panel (15 pharmacodynamic, 11 pharmacokinetic genes) assessing
    more than 700 medications, plus report sharing with the patient's provider at no extra cost.
  overage: null
  limits: []
  quote: '"$599 one-time payment when registering."'
  payment_methods:
  - major credit and debit cards
  - HSA
  - FSA
  - Apple Pay
  - Google Pay
  - PayPal
  - Venmo
  - Affirm (installment plans)
  source: https://genomind.com/cost-and-coverage/
unpriced_offerings:
- name: Provider / health-system ordering and EMR interface
  note: >-
    No published price. Genomind states insurance does not universally cover comprehensive PGx
    testing and reimbursement is not guaranteed; provider ordering runs through the provider
    portal and contracted EMR interfaces, both arranged through sales.
  source: https://genomind.com/who-we-support/providers/get-started/
- name: International ordering
  note: 'Pricing differs outside the US; the page directs non-US customers to contact Genomind.'
  source: https://genomind.com/cost-and-coverage/